Praxis Precision Medicines, Inc.
PRAX
$366.81
-$1.65-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 364.98% | 338.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 364.98% | 338.45% |
| Cost of Revenue | 30.96% | 52.65% | 75.26% | 114.73% | 146.94% |
| Gross Profit | -35.71% | -59.62% | -85.68% | -111.18% | -143.09% |
| SG&A Expenses | 52.45% | 33.05% | 4.93% | 6.98% | 28.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.37% | 48.19% | 56.29% | 81.48% | 107.75% |
| Operating Income | -39.24% | -53.36% | -62.96% | -78.71% | -104.67% |
| Income Before Tax | -35.10% | -53.62% | -65.88% | -80.80% | -102.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.10% | -53.62% | -65.88% | -80.80% | -102.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.10% | -53.62% | -65.88% | -80.80% | -102.85% |
| EBIT | -39.24% | -53.36% | -62.96% | -78.71% | -104.67% |
| EBITDA | -39.32% | -53.49% | -63.19% | -79.07% | -105.17% |
| EPS Basic | -5.32% | -24.90% | -31.18% | -25.34% | -19.64% |
| Normalized Basic EPS | -4.03% | -22.89% | -29.87% | -28.26% | -22.57% |
| EPS Diluted | -5.32% | -24.90% | -31.18% | -25.34% | -19.64% |
| Normalized Diluted EPS | -4.03% | -22.89% | -29.87% | -28.26% | -22.57% |
| Average Basic Shares Outstanding | 29.49% | 24.13% | 25.59% | 39.25% | 60.14% |
| Average Diluted Shares Outstanding | 29.49% | 24.13% | 25.59% | 39.25% | 60.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |